CeriBell (NASDAQ:CBLL – Get Free Report) released its quarterly earnings results on Tuesday. The company reported ($1.85) EPS for the quarter, missing the consensus estimate of ($0.82) by ($1.03), Zacks reports. The company had revenue of $17.20 million during the quarter, compared to the consensus estimate of $17.06 million.
CeriBell Stock Performance
NASDAQ:CBLL traded up $0.43 on Thursday, hitting $28.31. 29,204 shares of the stock were exchanged, compared to its average volume of 228,171. CeriBell has a fifty-two week low of $23.00 and a fifty-two week high of $29.53.
Wall Street Analysts Forecast Growth
Several equities analysts have issued reports on CBLL shares. William Blair started coverage on shares of CeriBell in a report on Tuesday, November 5th. They issued an “outperform” rating on the stock. Bank of America initiated coverage on shares of CeriBell in a report on Tuesday, November 5th. They set a “buy” rating and a $32.00 price target on the stock. TD Cowen initiated coverage on shares of CeriBell in a report on Tuesday, November 5th. They issued a “buy” rating and a $31.00 price target for the company. Canaccord Genuity Group lifted their target price on shares of CeriBell from $30.00 to $31.00 and gave the stock a “buy” rating in a research note on Wednesday. Finally, Canaccord Genuity Group initiated coverage on shares of CeriBell in a research report on Tuesday, November 5th. They set a “buy” rating and a $30.00 price objective for the company. Six analysts have rated the stock with a buy rating, According to MarketBeat, the stock has an average rating of “Buy” and an average target price of $31.20.
About CeriBell
We are a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. We have developed the Ceribell System, a novel, point-of-care electroencephalography (“EEG”) platform specifically designed to address the unmet needs of patients in the acute care setting.
Featured Stories
- Five stocks we like better than CeriBell
- Top Stocks Investing in 5G Technology
- 3 GARP Stocks Offering Strong Growth: Aptiv, Allstate, Barrick
- Stock Analyst Ratings and Canadian Analyst Ratings
- Mouse Rising: The Iger Investment Pays Off for Disney Investors
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Can CAVA Stock Be the Next Chipotle? Earnings Can Help
Receive News & Ratings for CeriBell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CeriBell and related companies with MarketBeat.com's FREE daily email newsletter.
